Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Clay

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Journal for Immunotherapy of Cancer|January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumorsCharles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
Future Oncology (London, England)|March 4, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or <i>HER2</i>-mutant solid tumorsAlison M Schram, John J Park, Antoine Italiano, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 17, 2025
Priority research directions for wildfire science: views from a historically fire-prone and an emerging fire-prone countryKerryn Little, Rayanne Vitali, Claire M Belcher, et al.
The Science of the Total Environment|November 17, 2020
Towards a microbial process-based understanding of the resilience of peatland ecosystem service provisioning - A research agendaJonathan P Ritson, Danielle M Alderson, Clare H Robinson, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Journal for Immunotherapy of Cancer|January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumorsCharles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
Future Oncology (London, England)|March 4, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or <i>HER2</i>-mutant solid tumorsAlison M Schram, John J Park, Antoine Italiano, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 17, 2025
Priority research directions for wildfire science: views from a historically fire-prone and an emerging fire-prone countryKerryn Little, Rayanne Vitali, Claire M Belcher, et al.
The Science of the Total Environment|November 17, 2020
Towards a microbial process-based understanding of the resilience of peatland ecosystem service provisioning - A research agendaJonathan P Ritson, Danielle M Alderson, Clare H Robinson, et al.
Pageof 18